skip to main content
Language:
Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients
Material Type:
Article 		Add to e-Shelf

A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients

Lee, Valerie ; Parkinson, Rose ; Zahurak, Marianna ; Cope, Leslie ; Cercek, Andrea ; Verheul, Henk ; Gootjes, Elske ; Lenz, Heinz Josef ; Iqbal, Syma ; Jones, Peter ; Baylin, Stephen ; Rami, Vandna ; Ahuja, Nita ; El Khoueiry, Anthony ; Azad, Nilofer S

International journal of cancer, 2024-05, Vol.154 (10), p.1794-1801 [Peer Reviewed Journal]

United States: Wiley Subscription Services, Inc

Full text available

Citations Cited by
2
SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4
SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4
Material Type:
Article 		Add to e-Shelf

SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4

Deysi Viviana T. Wong Helder Veras Ribeiro Filho; Carlos Wagner Souza Wanderley; Caio Abner Vitorino Gonçalves Leite; Jonilson Berlink Lima; Alexia Nathália Brígido Assef; Aurilene Gomes Cajado; Gabriela Loiola Ponte Batista; Rafael Holanda González; Karla Oliveira Silva; Luis Philipi Carvalho Borges; Nylane Maria Nunes de Alencar; Diego Veras Wilke; Thiago Mattar Cunha; Ana Carolina Migliorini Figueira; Fernando de Queiroz Cunha; Roberto César P Lima Júnior

Cancer Chemotherapy and Pharmacology Heidelberg v. 84, n. 2, p. 287-298, 2019

Heidelberg 2019

Available at FMRP - Fac. Medicina de Ribeirão Preto    (pcd 3011835 Acervo Digital )(GetIt)

3
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)
Material Type:
Article 		Add to e-Shelf

Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)

Sakai, Daisuke ; Taniguchi, Hiroya ; Sugimoto, Naotoshi ; Tamura, Takao ; Nishina, Tomohiro ; Hara, Hiroki ; Esaki, Taito ; Denda, Tadamichi ; Sakamoto, Takeshi ; Okuda, Hiroyuki ; Satoh, Taroh ; Tsushima, Takahiro ; Makiyama, Akitaka ; Tsuda, Takashi ; Hosokawa, Ayumu ; Kuramochi, Hidekazu ; Tokunaga, Shinya ; Moriwaki, Toshikazu ; Yasui, Hisateru ; Ishida, Hiroyasu ; Tsuji, Akihito ; Otsu, Satoshi ; Shimokawa, Hozumi ; Baba, Eishi ; Sato, Mikio ; Matsumoto, Shigemi ; Ozaki, Yukinori ; Shinozaki, Katsunori ; Tamagawa, Hiroshi ; Goto, Masahiro ; Kadowaki, Shigenori ; Fujii, Hirofumi ; Koh, Yasuhiro ; Yamazaki, Kentaro ; Hironaka, Shuichi ; Kishimoto, Junji ; Boku, Narikazu ; Hyodo, Ichinosuke ; Muro, Kei

European journal of cancer (1990), 2020-08, Vol.135, p.11-21 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available

Citations Cited by
4
Irinotecan- and 5-fluorouracil-induced intestinal mucositis insights into pathogenesis and therapeutic perspectives
Irinotecan- and 5-fluorouracil-induced intestinal mucositis insights into pathogenesis and therapeutic perspectives
Material Type:
Article 		Add to e-Shelf

Irinotecan- and 5-fluorouracil-induced intestinal mucositis insights into pathogenesis and therapeutic perspectives

Ronaldo A. Ribeiro Carlos W. S Wanderley; Deysi V. T Wong; José Maurício S. C Mota; Caio A. V. G Leite; Marcellus H. L. P Souza; Fernando de Queiroz Cunha; Roberto César P Lima Junior

Cancer Chemotherapy and Pharmacology Heidelberg v. 78, n. 5, p. 881-893, 2016

Heidelberg 2016

Available at FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2844973 Estantes Deslizantes )(GetIt)

5
Oxaliplatin versus irinotecan en el cáncer colorrectal avanzado: una revisión sistemática; Oxaliplatin versus Irinotecan in advanced colorectal cancer; Oxaliplatin versus Irinotecan no câncer colorretal avançado
Oxaliplatin versus irinotecan en el cáncer colorrectal avanzado: una revisión sistemática; Oxaliplatin versus Irinotecan in advanced colorectal cancer; Oxaliplatin versus Irinotecan no câncer colorretal avançado
Material Type:
Article 		Add to e-Shelf

Oxaliplatin versus irinotecan en el cáncer colorrectal avanzado: una revisión sistemática; Oxaliplatin versus Irinotecan in advanced colorectal cancer; Oxaliplatin versus Irinotecan no câncer colorretal avançado

Prado, Thais Arabe; Del Bel, Giovanna Volpe; Levignali, Milena Bongiorno; Resende, Uanderson

Medicina (Ribeirao Preto); Vol. 55 No. 3 (2022); e-189669

Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto 2022-11-09

Online access

6
Irinotecan
Irinotecan
Material Type:
Reference Entry 		Add to e-Shelf

Irinotecan

Odle, Teresa ; Scanio, Marc

The Gale Encyclopedia of Cancer : A Guide to Cancer and Its Treatments: Cr-Lo, 2021, p.1105-1107

Full text available

Citations Cited by
7
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
Material Type:
Article 		Add to e-Shelf

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

Cunningham, David ; Humblet, Yves ; Siena, Salvatore ; Khayat, David ; Bleiberg, Harry ; Santoro, Armando ; Bets, Danny ; Mueser, Matthias ; Harstrick, Andreas ; Verslype, Chris ; Chau, Ian ; Van Cutsem, Eric

The New England journal of medicine, 2004-07, Vol.351 (4), p.337-345 [Peer Reviewed Journal]

Boston, MA: Massachusetts Medical Society

Full text available

Citations Cited by
8
Irinotecan: 25 years of cancer treatment
Irinotecan: 25 years of cancer treatment
Material Type:
Article 		Add to e-Shelf

Irinotecan: 25 years of cancer treatment

Bailly, Christian

Pharmacological research, 2019-10, Vol.148, p.104398-104398, Article 104398 [Peer Reviewed Journal]

Netherlands: Elsevier Ltd

Full text available

Citations Cited by
9
Irinotecan pharmacogenomics
Irinotecan pharmacogenomics
Material Type:
Article 		Add to e-Shelf

Irinotecan pharmacogenomics

Marsh, Sharon ; Hoskins, Janelle M

Pharmacogenomics, 2010-07, Vol.11 (7), p.1003-1010 [Peer Reviewed Journal]

England: Future Medicine Ltd

Full text available

Citations Cited by
10
Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)
Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)
Material Type:
Article 		Add to e-Shelf

Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)

Ramaswamy, Anant ; Ostwal, Vikas ; Sharma, Atul ; Bhargava, Prabhat ; Srinivas, Sujay ; Goel, Mahesh ; Patkar, Shraddha ; Mandavkar, Sarika ; Jadhav, Poonam ; Parulekar, Manali ; Choudhari, Amitkumar ; Gupta, Sudeep

JAMA oncology, 2021-03, Vol.7 (3), p.436-439 [Peer Reviewed Journal]

United States: American Medical Association

Full text available

Citations Cited by
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Creation Date 

From To
Refine
  1. Before1993  (25)
  2. 1993To1999  (845)
  3. 2000To2006  (10,100)
  4. 2007To2014  (29,750)
  5. After 2014  (46,979)
  6. More options open sub menu

Language 

  1. English  (84,914)
  2. Japanese  (9,596)
  3. German  (954)
  4. French  (314)
  5. Spanish  (191)
  6. Korean  (124)
  7. Chinese  (87)
  8. Portuguese  (78)
  9. Polish  (66)
  10. Russian  (64)
  11. Norwegian  (32)
  12. Turkish  (29)
  13. Italian  (27)
  14. Dutch  (15)
  15. Czech  (5)
  16. Hungarian  (4)
  17. Croatian  (4)
  18. Catalan  (3)
  19. Swedish  (3)
  20. Persian  (2)
  21. Undetermined  (1)
  22. More options open sub menu

Suggested New Searches

Ignore my query and look for everything

by this author/creator:

  1. Hoff, P
  2. Cunha, F
  3. Souza, M
  4. Wong, D
  5. Costa, F

on this subject:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Oncology
  5. Chemotherapy

  • Implemented by: ABCD-USP USP   Social Network Logos: Freepik

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far